Improving Clinical Decision Making with Engaging CME, Tools, & Resources
Distinguishing Urgent vs. Monitorable Retinal Vein Occlusion
Ashkan Abbey, MD
Outcomes for PDR Patients LTFU for at Least 1 Year
Kyle Davis Kovacs, MD
Matt Starr, MD
Nita Valikodath, MD, MS
Hidden in Plain Sight: A Modern Guide to Detecting and Managing Early Neurotrophic Keratitis
March 12, 2026
Orlando, Florida
How Anti-VEGF Compares with Steroids in Retinal Vein Occlusion
Ryan Quigley
Patient at High Risk of Loss to Follow-Up, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
Deepak Sambhara, MD
A Case of Missed Diagnosis, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
Esther Lee Kim, MD
Overcoming Cultural and Communication Disconnects, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
David Chin Yee, MD, FASRS
It Takes a Village, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
David Eichenbaum, MD
Retinal Vein Occlusion: The Case for Prompt Treatment
Examining Therapeutic Timing in RVO-Related Macular Edema
Real-World Switching to Faricimab from Legacy Anti-VEGFs in Wet AMD
Maria H. Berrocal, MD
Lejla Vajzovic, MD, FASRS
Practice Efficiency and Innovation
Jacob Lang
Tailored Treatment in Retinal Disease: Using Biomarkers to Guide Anti-VEGF Therapy
Jennifer Caudle, DO, FACOFP
Michael Javaheri, MD, MSc, FASRS
Mapping the Landscape: Diagnostic Tools in Corneal Health
Paul Hammond, OD, FAAO
The Evolution of Retinal Vein Occlusion Treatment: From Laser to Anti-VEGF
Lisa Schocket, MD
Strategies for Addressing Complications in Retinal Vein Occlusion
Loading...
We're glad to see you're enjoying Eye Health Academy… but how about a more personalized experience?
Press cancel to remain on Eye Health Academy. Press the link below or the continue button to keep going.